These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1482141)

  • 1. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Bitonti AJ; Sjoerdsma A
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2736-40. PubMed ID: 1482141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.
    Bitonti AJ; Byers TL; Bush TL; Casara PJ; Bacchi CJ; Clarkson AB; McCann PP; Sjoerdsma A
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1485-90. PubMed ID: 1977366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
    Bacchi CJ; Brun R; Croft SL; Alicea K; Bühler Y
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1448-53. PubMed ID: 8726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense.
    Brun R; Burri C; Gichuki CW
    Trop Med Int Health; 2001 May; 6(5):362-8. PubMed ID: 11348531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.
    Bacchi CJ; Garofalo J; Ciminelli M; Rattendi D; Goldberg B; McCann PP; Yarlett N
    Biochem Pharmacol; 1993 Aug; 46(3):471-81. PubMed ID: 8347171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.
    Bacchi CJ; Barker RH; Rodriguez A; Hirth B; Rattendi D; Yarlett N; Hendrick CL; Sybertz E
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3269-72. PubMed ID: 19451291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
    Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
    Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.
    Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.
    Byers TL; Bush TL; McCann PP; Bitonti AJ
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):527-33. PubMed ID: 1672500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.
    Brockway AJ; Volkov OA; Cosner CC; MacMillan KS; Wring SA; Richardson TE; Peel M; Phillips MA; De Brabander JK
    Bioorg Med Chem; 2017 Oct; 25(20):5433-5440. PubMed ID: 28807574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.
    Iten M; Mett H; Evans A; Enyaru JC; Brun R; Kaminsky R
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1922-5. PubMed ID: 9303385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.
    Bacchi CJ; Berens RL; Nathan HC; Klein RS; Elegbe IA; Rao KV; McCann PP; Marr JJ
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1406-13. PubMed ID: 3118799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT).
    Hirth B; Barker RH; Celatka CA; Klinger JD; Liu H; Nare B; Nijjar A; Phillips MA; Sybertz E; Willert EK; Xiang Y
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2916-9. PubMed ID: 19419862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.